Question 1

What did the study find?

Accepted Answer

Higher pre-operative UTE-T2* in deep medial femoral cartilage and medial meniscus was associated with worse 11-year KOOS Symptoms scores (adjusted R2 = 0.146-0.332); higher femoral cartilage UTE-T2* trended with lower Marx activity scores (adjusted R2 = 0.208, p = 0.056, non-significant), while higher posterior meniscus UTE-T2* was associated with higher Marx scores (adjusted R2 = 0.308); in the 11-patient radiographic subset, median posterior meniscus UTE-T2* was 69% higher in those with radiographic knee OA.

Question 2

What was the study design?

Accepted Answer

Retrospective analysis of a prospectively acquired cohort, n=22 for clinical outcomes and only n=11 for radiographs, single centre, Level 3 evidence sitting near the bottom of the hierarchy for prognostic studies, far below a prospective cohort powered for this question.

Question 3

How trustworthy is the methodology?

Accepted Answer

The sample is tiny, especially the 11-patient radiographic subgroup used for the 69% KOA comparison, which makes that figure essentially anecdotal. Multiple regression models and subgroup comparisons were run across several cartilage and meniscus compartments without clear correction for multiple comparisons, raising real risk of false-positive associations, and the R2 values reported (0.15-0.33) mean 67-85% of the variance in symptoms or activity is unexplained by UTE-T2*. Attrition over an 11-year follow-up and selection into who returned for imaging and PROMs is not detailed, and there's no blinding issue to speak of since this is imaging-outcome correlation, but confounding by rehabilitation, further injury, and activity level over a decade is poorly controlled. A clinician could ascertain UTE-T2* only via specialised 3T UTE sequences that are not part of standard clinical MRI protocols.

Question 4

What is the overall appraisal?

Accepted Answer

The statistical associations are plausible and biologically sensible, but with R2 values this low the clinical predictive value for an individual patient is weak, most of the outcome variance is unexplained, and the trend for Marx scores didn't even reach significance. This is hypothesis-generating correlational data from a very small, likely underpowered sample, not evidence that UTE-T2* should guide any treatment decision.

Question 5

What is the main limitation?

Accepted Answer

A larger, prospective, multicentre cohort with pre-specified primary outcomes and correction for multiple comparisons is needed before UTE-T2* can be treated as a validated prognostic biomarker; right now the radiographic subgroup of 11 is far too small to support the headline 69% figure.

Question 6

What should clinicians do on Monday?

Accepted Answer

This does not change Monday practice for physios or S&C coaches. UTE-T2* mapping is a research sequence, not available on routine clinical MRI, and even where it is available, the predictive strength shown here (adjusted R2 0.15-0.33, one trend not statistically significant) is too weak to inform individual patient counselling, rehab progression, or return-to-sport and training-load decisions. Standard post-ACLR monitoring, meniscus status at surgery, strength testing, KOOS and activity tracking, remains the actionable toolkit.

Question 7

How do I apply this in practice?

Accepted Answer

This applies to ACLR patients with a documented medial meniscus tear or chondral lesion at time of surgery, the subgroup where this signal lives. In the clinic, nothing changes today: you can't order a UTE-T2* scan, so keep counselling and rehab decisions anchored to what you can measure, meniscus status at surgery, pain on loading, KOOS trajectory, and strength testing. For S&C, treat baseline medial meniscus/cartilage pathology as a soft long-term flag worth noting in the athlete's file, not a reason to cap training load or alter RTS criteria, since an R2 this low means most of the variance in long-term symptoms and activity level is coming from somewhere else entirely. The one caveat in applying it: this is a 22-person correlational cohort, so it should nudge your index of suspicion, not your decisions.

Evaluation of Pre-Operative Cartilage and Meniscus Ultrashort Echo Time T2* as Biomarkers of Long-Term Clinical Outcomes Following Anterior Cruciate Ligament Reconstruction

The paper

What they found

Study design

Methodology

The appraisal

The gap

Landmark context

What to do Monday

In practice

The five papers that matter — every week, free.

Related appraisals